<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35627483</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>31</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1660-4601</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>10</Issue><PubDate><Year>2022</Year><Month>May</Month><Day>13</Day></PubDate></JournalIssue><Title>International journal of environmental research and public health</Title><ISOAbbreviation>Int J Environ Res Public Health</ISOAbbreviation></Journal><ArticleTitle>Circulating Trends of Influenza and Other Seasonal Respiratory Viruses among the US Department of Defense Personnel in the United States: Impact of the COVID-19 Pandemic.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">5942</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijerph19105942</ELocationID><Abstract><AbstractText>The objective of this study was to evaluate the impact of the COVID-19 pandemic on the circulation of influenza and other seasonal respiratory viruses in the United States. All data were obtained from the US Department of Defense Global Respiratory Pathogen Surveillance Program over five consecutive respiratory seasons from 2016-2017 through to 2020-2021. A total of 62,476 specimens were tested for seasonal respiratory viruses. The circulating patterns of seasonal respiratory viruses have been greatly altered during the pandemic. The 2019-2020 influenza season terminated earlier compared to the pre-pandemic seasons, and the 2020-2021 influenza season did not occur. Moreover, weekly test positivity rates dramatically decreased for most of the seasonal respiratory viruses from the start of the pandemic through spring 2021. After the easing of non-pharmaceutical interventions (NPIs), circulations of seasonal coronavirus, parainfluenza, and respiratory syncytial virus have returned since spring 2021. High rhinovirus/enterovirus activity was evident throughout the 2020-2021 respiratory season. The findings suggest a strong association between the remarkably changed activity of seasonal respiratory viruses and the implementation of NPIs during the COVID-19 pandemic. The NPIs may serve as an effective public health tool to reduce transmissions of seasonal respiratory viruses.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Wenping</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>The Department of Defense Global Emerging Infections Surveillance Branch, Armed Forces Health Surveillance Division, Wright-Patterson Air Force Base, Dayton, OH 45433, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>JYG Innovations LLC, Dayton, OH 45414, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fries</LastName><ForeName>Anthony C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>U.S. Air Force School of Aerospace Medicine, Wright-Patterson Air Force Base, Dayton, OH 45433, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DeMarcus</LastName><ForeName>Laurie S</ForeName><Initials>LS</Initials><AffiliationInfo><Affiliation>The Department of Defense Global Emerging Infections Surveillance Branch, Armed Forces Health Surveillance Division, Wright-Patterson Air Force Base, Dayton, OH 45433, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>JYG Innovations LLC, Dayton, OH 45414, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thervil</LastName><ForeName>Jeffery W</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>The Department of Defense Global Emerging Infections Surveillance Branch, Armed Forces Health Surveillance Division, Wright-Patterson Air Force Base, Dayton, OH 45433, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>JYG Innovations LLC, Dayton, OH 45414, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwaah</LastName><ForeName>Bismark</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>The Department of Defense Global Emerging Infections Surveillance Branch, Armed Forces Health Surveillance Division, Wright-Patterson Air Force Base, Dayton, OH 45433, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>JYG Innovations LLC, Dayton, OH 45414, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Kayla N</ForeName><Initials>KN</Initials><AffiliationInfo><Affiliation>The Department of Defense Global Emerging Infections Surveillance Branch, Armed Forces Health Surveillance Division, Wright-Patterson Air Force Base, Dayton, OH 45433, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>JYG Innovations LLC, Dayton, OH 45414, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sjoberg</LastName><ForeName>Paul A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>The Department of Defense Global Emerging Infections Surveillance Branch, Armed Forces Health Surveillance Division, Wright-Patterson Air Force Base, Dayton, OH 45433, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>JYG Innovations LLC, Dayton, OH 45414, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robbins</LastName><ForeName>Anthony S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>The Department of Defense Global Emerging Infections Surveillance Branch, Armed Forces Health Surveillance Division, Wright-Patterson Air Force Base, Dayton, OH 45433, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Environ Res Public Health</MedlineTA><NlmUniqueID>101238455</NlmUniqueID><ISSNLinking>1660-4601</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="Y">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012621" MajorTopicYN="N">Seasons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014780" MajorTopicYN="Y">Viruses</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">influenza</Keyword><Keyword MajorTopicYN="N">pandemic</Keyword><Keyword MajorTopicYN="N">respiratory virus</Keyword><Keyword MajorTopicYN="N">surveillance</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results. <b>Disclaimer:</b> The views expressed are those of the authors and do not reflect the official guidance or position of the United States Government, the Department of Defense, or of the United States Air Force.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>4</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>28</Day><Hour>1</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>5</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35627483</ArticleId><ArticleId IdType="pmc">PMC9141702</ArticleId><ArticleId IdType="doi">10.3390/ijerph19105942</ArticleId><ArticleId IdType="pii">ijerph19105942</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Avadhanula V., Piedra P.A. The prevention of common respiratory virus epidemics in 2020&#x2013;21 during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic: An unexpected benefit of the implementation of public health measures. Lancet Reg. Health-Am. 2021;2:100043. doi: 10.1016/j.lana.2021.100043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lana.2021.100043</ArticleId><ArticleId IdType="pmc">PMC8377442</ArticleId><ArticleId IdType="pubmed">34430955</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai S., Ruktanonchai N.W., Zhou L., Prosper O., Luo W., Floyd J.R., Wesolowski A., Santillana M., Zhang C., Du X., et al. Effect of non-pharmaceutical interventions to contain COVID-19 in China. Nature. 2020;585:410&#x2013;413. doi: 10.1038/s41586-020-2293-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2293-x</ArticleId><ArticleId IdType="pmc">PMC7116778</ArticleId><ArticleId IdType="pubmed">32365354</ArticleId></ArticleIdList></Reference><Reference><Citation>Flaxman S., Mishra S., Gandy A., Unwin H.J.T., Mellan T.A., Coupland H., Whittaker C., Zhu H., Berah T., Eaton J.W., et al. Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. Nature. 2020;584:257&#x2013;261. doi: 10.1038/s41586-020-2405-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2405-7</ArticleId><ArticleId IdType="pubmed">32512579</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen S.J., Winn A.K., Budd A.P., Prill M.M., Steel J., Midgley C.M., Kniss K., Burns E., Rowe T., Foust A., et al. Changes in influenza and other respiratory virus activity during the COVID-19 pandemic-United States, 2020&#x2013;2021. MMWR. 2021;70:1013&#x2013;1019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8297694</ArticleId><ArticleId IdType="pubmed">34292924</ArticleId></ArticleIdList></Reference><Reference><Citation>Arellanos-Soto D., Padilla-Rivas G., Ramos-Jimenez J., Galan-Huerta K., Lozano-Sepulveda S., Martinez-Acu&#xf1;a N., Trevi&#xf1;o-Garza C., Montes-de-Oca-Luna R., de-la-O-Cavazos M., Rivas-Estilla A.M. Decline in influenza cases in Mexico after the implementation of public health measures for COVID-19. Sci. Rep. 2021;11:10730. doi: 10.1038/s41598-021-90329-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-90329-w</ArticleId><ArticleId IdType="pmc">PMC8144183</ArticleId><ArticleId IdType="pubmed">34031515</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H., Lee H., Song K.-H., Kim E.S., Park J.S., Jung J., Ahn S., Jeong E.K., Park H., Kim H.B. Impact of public health interventions on seasonal influenza activity during the COVID-19 outbreak in Korea. Clin. Infect. Dis. 2021;73:e132&#x2013;e140. doi: 10.1093/cid/ciaa672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa672</ArticleId><ArticleId IdType="pmc">PMC7314207</ArticleId><ArticleId IdType="pubmed">32472687</ArticleId></ArticleIdList></Reference><Reference><Citation>Emborg H.-D., Carnahan A., Bragstad K., Trebbien R., Brytting M., Hungnes O., Bystr&#xf6;m E., Vestergaard L.S. Abrupt termination of the 2019/20 influenza season following preventive measures against COVID-19 in Denmark, Norway and Sweden. Eurosurveillance. 2021;26:2001160. doi: 10.2807/1560-7917.ES.2021.26.22.2001160.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2021.26.22.2001160</ArticleId><ArticleId IdType="pmc">PMC8176675</ArticleId><ArticleId IdType="pubmed">34085632</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen S.J., Azziz-Baumgartner E., Budd A.P., Brammer L., Sullivan S., Pineda R.F., Cohen C., Fry A.M. Decreased influenza activity during the COVID-19 pandemic-United States, Australia, Chile, and South Africa, 2020. MMWR. 2020;69:1305&#x2013;1309.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7498167</ArticleId><ArticleId IdType="pubmed">32941415</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Q.S., Wood T., Jelley L., Jennings T., Jefferies S., Daniells K., Nesdale A., Dowell T., Turner N., Campbell-Stokes P., et al. Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand. Nat. Commun. 2021;12:1001. doi: 10.1038/s41467-021-21157-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21157-9</ArticleId><ArticleId IdType="pmc">PMC7881137</ArticleId><ArticleId IdType="pubmed">33579926</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan S.G., Carlson S., Cheng A.C., Chilver M.B.N., Dwyer D.E., Irwin M., Kok J., Macartney K., MacLachlan J., Minney-Smith C., et al. Where has all the influenza gone? The impact of COVID-19 on the circulation of influenza and other respiratory viruses, Australia, March to September 2020. Eurosurveillance. 2020;25:2001847. doi: 10.2807/1560-7917.ES.2020.25.47.2001847.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2020.25.47.2001847</ArticleId><ArticleId IdType="pmc">PMC7693168</ArticleId><ArticleId IdType="pubmed">33243355</ArticleId></ArticleIdList></Reference><Reference><Citation>Tempia S., Walaza S., Bhiman J.N., McMorrow M.L., Moyes J., Mkhencele T., Meiring S., Quan V., Bishop K., McAnerney J.M., et al. Decline of influenza and respiratory syncytial virus detection in facility-based surveillance during the COVID-19 pandemic, South Africa, January to October 2020. Eurosurveillance. 2021;26:2001600. doi: 10.2807/1560-7917.ES.2021.26.29.2001600.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2021.26.29.2001600</ArticleId><ArticleId IdType="pmc">PMC8299743</ArticleId><ArticleId IdType="pubmed">34296675</ArticleId></ArticleIdList></Reference><Reference><Citation>Agha R., Avner J.R. Delayed seasonal RSV surge observed during the COVID-19 pandemic. Pediatrics. 2021;148:e2021052089. doi: 10.1542/peds.2021-052089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2021-052089</ArticleId><ArticleId IdType="pubmed">34108234</ArticleId></ArticleIdList></Reference><Reference><Citation>Casalegno J.-S., Ploin D., Cantais A., Masson E., Bard E., Valette M., Fanget R., Targe S.C., Myar-Dury A.-F., Doret-Dion M., et al. Characteristics of the delayed respiratory syncytial virus epidemic, 2020/2021, Rh&#xf4;ne Loire, France. Eurosurveillance. 2021;26:2100630. doi: 10.2807/1560-7917.ES.2021.26.29.2100630.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2021.26.29.2100630</ArticleId><ArticleId IdType="pmc">PMC8299747</ArticleId><ArticleId IdType="pubmed">34296674</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Summeren J., Meijer A., Aspelund G., Casalegno J.S., Erna G., Hoang U., Lina B., VRS study group in Lyon. de Lusignan S., Teirlinck A.C., et al. Low levels of respiratory syncytial virus activity in Europe during the 2020/21 season: What can we expect in the coming summer and autumn/winter? Eurosurveillance. 2021;26:2100639. doi: 10.2807/1560-7917.ES.2021.26.29.2100639.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2021.26.29.2100639</ArticleId><ArticleId IdType="pmc">PMC8299745</ArticleId><ArticleId IdType="pubmed">34296672</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng L., Zhang T., Wang Q., Xie Y., Peng Z., Zheng J., Qin Y., Zhang M., Lai S., Wang D., et al. Impact of COVID-19 outbreaks and interventions on influenza in China and the United States. Nat. Commun. 2021;12:3249. doi: 10.1038/s41467-021-23440-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-23440-1</ArticleId><ArticleId IdType="pmc">PMC8167168</ArticleId><ArticleId IdType="pubmed">34059675</ArticleId></ArticleIdList></Reference><Reference><Citation>Laurie K.L., Rockman S. Which influenza viruses will emerge following the SARS-CoV-2 pandemic? Influenza Other Respir. Viruses. 2021;15:573&#x2013;576. doi: 10.1111/irv.12866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/irv.12866</ArticleId><ArticleId IdType="pmc">PMC8242426</ArticleId><ArticleId IdType="pubmed">33955176</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez G.B., Mah&#xe9; C., Chaves S.S. Uncertain effects of the pandemic on respiratory viruses. Science. 2021;372:1043&#x2013;1044. doi: 10.1126/science.abh3986.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abh3986</ArticleId><ArticleId IdType="pubmed">34083477</ArticleId></ArticleIdList></Reference><Reference><Citation>Moriyama M., Hugentobler W.J., Iwasaki A. Seasonality of Respiratory Viral Infections. Annu. Rev. Virol. 2020;7:83&#x2013;101. doi: 10.1146/annurev-virology-012420-022445.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-virology-012420-022445</ArticleId><ArticleId IdType="pubmed">32196426</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh D.-Y., Buda S., Biere B., Reiche J., Schlosser F., Duwe S., Wedde M., von Kleist M., Mielke M., Wolff T., et al. Trends in respiratory virus circulation following COVID-19-targeted nonpharmaceutical interventions in Germany, January-September 2020: Analysis of national surveillance data. Lancet Reg. Health-Eur. 2021;6:100112. doi: 10.1016/j.lanepe.2021.100112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100112</ArticleId><ArticleId IdType="pmc">PMC8183189</ArticleId><ArticleId IdType="pubmed">34124707</ArticleId></ArticleIdList></Reference><Reference><Citation>Doroshenko A., Lee N., MacDonald C., Zelyas N., Asadi L., Kanji J.N. Decline of influenza and respiratory viruses with COVID-19 public health measures: Alberta, Canada. Mayo Clin. Proc. 2021;96:3042&#x2013;3052. doi: 10.1016/j.mayocp.2021.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2021.09.004</ArticleId><ArticleId IdType="pmc">PMC8450272</ArticleId><ArticleId IdType="pubmed">34863395</ArticleId></ArticleIdList></Reference><Reference><Citation>Groves H.E., Pich&#xe9;-Renaud P.-P., Peci A., Farrar D.S., Buckrell S., Bancej C., Sevenhuysen C., Campigotto A., Gubbay J.B., Morris S.K. The impact of the COVID-19 pandemic on influenza, respiratory syncytial virus and other seasonal respiratory virus circulation in Canada: A population-based study. Lancet Reg. Health-Am. 2021;1:100015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8285668</ArticleId><ArticleId IdType="pubmed">34386788</ArticleId></ArticleIdList></Reference><Reference><Citation>Park K.Y., Seo S., Han J., Park J.Y. Respiratory virus surveillance in Canada during the COVID-19 pandemic: An epidemiological analysis of the effectiveness of pandemic-related public health measures in reducing seasonal respiratory viruses test positivity. PLoS ONE. 2021;16:e0253451. doi: 10.1371/journal.pone.0253451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0253451</ArticleId><ArticleId IdType="pmc">PMC8213179</ArticleId><ArticleId IdType="pubmed">34143839</ArticleId></ArticleIdList></Reference><Reference><Citation>Poole S., Brendish N.J., Tanner A.R., Clark T.W. Physical distancing in schools for SARS-CoV-2 and the resurgence of rhinovirus. Lancet Respir. Med. 2020;8:e92&#x2013;e93. doi: 10.1016/S2213-2600(20)30502-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30502-6</ArticleId><ArticleId IdType="pmc">PMC7581315</ArticleId><ArticleId IdType="pubmed">33289636</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiseleva I., Ksenafontov A. COVID-19 shuts doors to flu but keeps them open to rhinoviruses. Biology. 2021;10:733. doi: 10.3390/biology10080733.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology10080733</ArticleId><ArticleId IdType="pmc">PMC8389621</ArticleId><ArticleId IdType="pubmed">34439965</ArticleId></ArticleIdList></Reference><Reference><Citation>Britton P.N., Hu N., Saravanos G., Shrapnel J., Davis J., Snelling T., Dalby-Payne J., Kesson A.M., Wood N., Macartney K., et al. COVID-19 public health measures and respiratory syncytial virus. Lancet Child Adolesc. Health. 2020;4:e42&#x2013;e43. doi: 10.1016/S2352-4642(20)30307-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(20)30307-2</ArticleId><ArticleId IdType="pmc">PMC7500894</ArticleId><ArticleId IdType="pubmed">32956616</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs S.E., Lamson D.M., St. George K., Walsh T.J. Human rhinoviruses. Clin. Microbiol. Rev. 2013;26:135&#x2013;162. doi: 10.1128/CMR.00077-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00077-12</ArticleId><ArticleId IdType="pmc">PMC3553670</ArticleId><ArticleId IdType="pubmed">23297263</ArticleId></ArticleIdList></Reference><Reference><Citation>McNab S., Do L.A.H., Clifford V., Crawford N.W., Daley A., Mulholland K., Cheng D., South M., Waller G., Barr I., et al. Changing epidemiology of respiratory syncytial virus in Australia-delayed re-emergence in Victoria compared to Western Australia/New South Wales (WA/NSW) after prolonged lock-down for coronavirus disease 2019 (COVID-19) Clin. Infect. Dis. 2021;73:2365&#x2013;2366. doi: 10.1093/cid/ciab240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab240</ArticleId><ArticleId IdType="pmc">PMC7989588</ArticleId><ArticleId IdType="pubmed">33735388</ArticleId></ArticleIdList></Reference><Reference><Citation>Foley D.A., Yeoh D.K., Minney-Smith C.A., Martin A.C., Mace A.O., Sikazwe C.T., Le H., Levy A., Moore H.C., Blyth C.C. The interseasonal resurgence of respiratory syncytial virus in Australian children following the reduction of coronavirus disease 2019-related public health measures. Clin. Infect. Dis. 2021;73:e2829&#x2013;e2830. doi: 10.1093/cid/ciaa1906.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1906</ArticleId><ArticleId IdType="pmc">PMC7929151</ArticleId><ArticleId IdType="pubmed">33594407</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodjat P., Christensen P.A., Subedi S., Bernard D.W., Olsen R.J., Long S.W. The reemergence of seasonal respiratory viruses in Houston, Texas, after relaxing COVID-19 restrictions. Microbiol. Spectr. 2021;9:e00430-21. doi: 10.1128/Spectrum.00430-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/Spectrum.00430-21</ArticleId><ArticleId IdType="pmc">PMC8557899</ArticleId><ArticleId IdType="pubmed">34494861</ArticleId></ArticleIdList></Reference><Reference><Citation>The Academy of Medical Sciences . COVID-19: Preparing for the Future. Looking Ahead to Winter 2021/22 and Beyond. The Academy of Medical Sciences; London, UK: 2021. pp. 4&#x2013;9.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>